Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Apr 5;16:911–924. doi: 10.2147/CCID.S400605

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 Viscomi et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Clinical case 2: 54-year-old woman. A 0.6mL supraperiosteal bolus of HAI was injected in in the pogonium (most anterior point of the chin) and 0.7mL of HAI was injected in each side of the pre-jowl sulcus. A total volume of 1.0mL of CaHA(+) per side was injected in the subcutaneous layer, slightly below the mandible ramus, along its length, while 0.5mL of HAV was injected in the superficial subcutaneous layer along the mandible ramus for further definition. Images taken with Vectra Software. at baseline (A, D, G, J, M), after 30 days (B, E, H, K, N) and 90 days (C, F, I, L, O) after the treatment session.